Nanochon closes $4M Series Seed Prime

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: May 19, 2024

Rockwell Institute Celebrates Highest Real Estate Exam Pass Rates for First-Time Test Takers in the State of Washington • Angels Helpers NYC 2024 Charity Gala Raises Funds for Harlem School of the Arts, Highbridge Voices • The AZEK Company Receives NYSE Notice Regarding Filing of Form 10-Q for the Fiscal Quarter Ended March 31, 2024 • Historic Inaugural Class Graduates from OSU College of Osteopathic Medicine at the Cherokee Nation • Statement by the Prime Minister on Tamil Genocide Remembrance Day • L.A. Care and Blue Shield of California Promise Health Plans Unveil New, Vibrant Community Resource Center in Panorama City with • Upneeq® Wins 2024 Shape Skin Award, “Best for Lift”, in the Professional Treatment Category • Sacred Heart Celebrates 125th Anniversary • After Launching Massive Camp Giveaway for NYC Families Affected by "Summer Rising" Crisis, Brains & Motion Education (BAM!) • WOMEN'S HEALTHCARE COMPANY WATKINS-CONTI RECEIVES FDA 510(K) CLEARANCE FOR NEW STRESS URINARY INCONTINENCE DEVICE YŌNI.FIT& • HERImpact: Entrepreneurship for Impact Program Kicks Off in Chicago, Empowering Women Entrepreneurs • May and Stanley Smith Charitable Trust Partners with American Indian College Fund to Support Native Student Veterans • Xylem Inc. Declares Second Quarter Dividend of 36 Cents per Share • Avangrid to Be Acquired by Iberdrola • Dillard’s, Inc. Announces $0.25 Cash Dividend • Energy Vault Holdings, Inc. Announces Inducement Grants Under NYSE Listing Rule 303A.08 • Red Door Community Raises more than $300,000 at Their Annual Luncheon Celebrating Women Working and Living with Cancer • Aramco and Spiritus to Advance Direct Air Capture Technology, Investment by Aramco Ventures • Federal, provincial and territorial ministers gather to support culture and heritage at annual meeting • Historic Bellevue House reopens

Nanochon closes $4M Series Seed Prime

WASHINGTON , May 06 /Businesswire/ - Nanochon, a Washington, DC-based orthopedic device biotech company has raised $4 million in its series seed prime fundraising round.

The round was led by The University of Virginia Licensing and Ventures Group Seed Fund, with participation from Cultivate (MD), Alumni Venture Group, and Mountain State Capital, among others.

Nanochon intends to use the funds to initiate its first in human clinical trials in the US in 2024, deepen research and development efforts, expand the company’s patent profile and grow its team.

“We’re thrilled to close our funding round and begin our clinical program,” says Ben Holmes, CEO and co-founder. “Securing this funding is one step closer towards achieving Nanochon’s goals of eliminating the need for knee replacements, and greatly shifting the paradigm of arthritic joint care.”

Nanochon will initiate a phase I trial in the US this year for its patented knee implant Chondrograft™. The device requires only minimally invasive surgery to regrow damaged cartilage and bone to stave off the need for full knee replacements which are costly and have a long recovery time.

Holmes follows, “We’ve had fantastic success in our animal studies and we’re very optimistic about future implications in human knees and other joints.”

Nanochon is a biotech and medical device company focused on developing innovative orthopedic solutions. Chondrograft™ is a minimally-invasive implant that allows for immediate weight-bearing and motion – meaning less time spent recovering. Nanochon has the potential to deliver more successful and longer-lasting recovery for patients than current standard of care. Our mission is to develop a new approach to treat cartilage replacement and repair so that the hundreds of thousands of young, active patients with joint damage can return to their lifestyles without having to undergo costly and invasive short-term fixes.